Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA. * The funding opportunity is for a planning grant to support the development of a product development strategy. * The grant is for a maximum of $225,000. * The application is due by December 4, 2026. * The opportunity is open to various types of organizations, including non-profits, small businesses, and institutions of higher education.